new glp-1 weight loss List of approved and pending medications With FDA approval of Wegovy

Retatrutide , a triple agonist targeting GLP-1, GIP, and glucagon receptors, has shown even more dramatic weight loss in clinical trials, with some participants losing over 25% of their body weight

At TrimRx, our mission is to help individuals embrace healthier lifestyles through science, empathy, and a transparent approach to sustainable weight loss

And I was in practice for a decade before I closed my practice right before COVID

Naturally, when you eat a meal, your intestines release GLP-1

Sofwave Recovery* As a quick, non-invasive, in-office treatment, Sofwave offers convenience and ease

This approach is particularly relevant in 2026, as demand for GLP-1 therapies continues to outpace traditional access models